caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1568405868

James ThompsonMD

PRACTICEZAHID ASGHER MDSee all providers at this practice →
HematologyBuffalo, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where James Thompson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Edward Spangenthal
Cardiology · Williamsville, NY
351,233
Kazunori Kanehira
Pathology · Buffalo, NY
30412
Eunice Wang
Hematology · Buffalo, NY
221,369
Michael Ryan
Physician Assistant · Buffalo, NY
22209
Julie Kwoka
Nurse Practitioner · Buffalo, NY
19841
KLIEGER, PETER18214
GURTOO, LALIT17212
Samuel S'doia
Diagnostic Radiology · Williamsville, NY
16230
Ronald Alberico
Diagnostic Radiology · Buffalo, NY
15205
Janine Milligan
Diagnostic Radiology · Buffalo, NY
13129
Maureen Ross
Internal Medicine · Buffalo, NY
13479
Fadi Habib
Pathology · York, PA
1299
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
112
Unique beneficiaries
—
Total services
217
Distinct HCPCS
6
Medicare payment
$14K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 102 Hematology providers in NY — below median (cohort median 474).
PRESCRIBING · PART D · 2024
Total Rx claims
589
Beneficiaries
—
Total drug cost
$5.7M
Distinct drugs
13
Brand share
66.0%
Top prescribed drugs
Imatinib Mesylate99 claims
Dasatinib89 claims
Hydroxyurea81 claims
Bosutinib80 claims
Decitabine/Cedazuridine46 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.